The progress and prospects of routine prophylactic antiviral treatment in hepatitis B-related hepatocellular carcinoma

•Antiviral treatment is an important adjuvant therapy in HCC treatments.•Antiviral treatment is a feasible and effective strategy to prevent HCC in viral hepatitis patients.•Antiviral treatment can increase the survival rate as well as the quality of life of hepatitis B-related HCC patients.•Prophylactic antiviral treatment should be routinely performed as an important adjuvant therapy in HBV-related HCC patients.